JP2021522345A5 - - Google Patents
Info
- Publication number
- JP2021522345A5 JP2021522345A5 JP2021509963A JP2021509963A JP2021522345A5 JP 2021522345 A5 JP2021522345 A5 JP 2021522345A5 JP 2021509963 A JP2021509963 A JP 2021509963A JP 2021509963 A JP2021509963 A JP 2021509963A JP 2021522345 A5 JP2021522345 A5 JP 2021522345A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cancer
- subject
- administering
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862662637P | 2018-04-25 | 2018-04-25 | |
| US62/662,637 | 2018-04-25 | ||
| PCT/US2019/029192 WO2020033019A2 (en) | 2018-04-25 | 2019-04-25 | Novel mct4 inhibitors and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021522345A JP2021522345A (ja) | 2021-08-30 |
| JPWO2020033019A5 JPWO2020033019A5 (https=) | 2022-04-28 |
| JP2021522345A5 true JP2021522345A5 (https=) | 2022-04-28 |
| JP7115671B2 JP7115671B2 (ja) | 2022-08-09 |
Family
ID=68532786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021509963A Active JP7115671B2 (ja) | 2018-04-25 | 2019-04-25 | 新規なｍｃｔ４阻害剤及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10919878B2 (https=) |
| EP (1) | EP3784650B1 (https=) |
| JP (1) | JP7115671B2 (https=) |
| CN (1) | CN112888673B (https=) |
| AU (1) | AU2019317518B2 (https=) |
| CA (1) | CA3098189C (https=) |
| WO (1) | WO2020033019A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12544375B2 (en) * | 2019-09-05 | 2026-02-10 | The Board Of Trustees Of The Leland Junior University | Small molecule therapeutic for parkinson's disease paired with a biomarker of therapeutic activity |
| WO2021249969A1 (en) * | 2020-06-10 | 2021-12-16 | Merck Patent Gmbh | Combination product for the treatment of cancer diseases |
| WO2022243573A1 (en) | 2021-05-21 | 2022-11-24 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | 1,2,4-triazolo[1,5-a]pyrimidine-based slc16a3 inhibitors and their therapeutic use |
| WO2022243574A1 (en) | 2021-05-21 | 2022-11-24 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | 3-(phthalazin-1-yl)benzenesulfonamide-based slc16a3 inhibitors and their therapeutic use |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1226438A (https=) | 1968-12-03 | 1971-03-31 | ||
| GB0327734D0 (en) * | 2003-11-28 | 2003-12-31 | Novartis Ag | Organic compounds |
| TW200804349A (en) * | 2005-12-23 | 2008-01-16 | Kalypsys Inc | Novel substituted pyrimidinyloxy ureas as inhibitors of protein kinases |
| WO2010089580A1 (en) * | 2009-02-06 | 2010-08-12 | Astrazeneca Ab | Use of a mct1 inhibitor in the treatment of cancers expressing mct1 over mct4 |
| CN102731413A (zh) * | 2011-04-15 | 2012-10-17 | 上海医药工业研究院 | 一种脲类化合物、其制备方法、其中间体及其应用 |
| CN105263484B (zh) | 2013-05-24 | 2018-08-03 | 株式会社加龄.营养研究所 | 包含二甲双胍和二氢槲皮素的药物组合及其用于治疗癌症的用途 |
| CN107406390B (zh) * | 2014-11-17 | 2021-04-16 | 奈吉治疗公司 | 单羧酸转运蛋白调节剂及其用途 |
| EP3247349B1 (en) * | 2015-01-22 | 2019-12-11 | The Scripps Research Institute | Chromenone inhibitors of monocarboxylate transporters |
| US10328078B2 (en) * | 2015-01-22 | 2019-06-25 | The Scripps Research Institute | Pteridine dione monocarboxylate transporter inhibitors |
| BR112017026535B1 (pt) * | 2015-06-12 | 2023-12-19 | Vettore, LLC | Composto e composição farmacêutica |
| CN108368060B (zh) * | 2017-12-21 | 2020-09-15 | 中国科学院合肥物质科学研究院 | 一类嘧啶类衍生物激酶抑制剂 |
-
2019
- 2019-04-25 CA CA3098189A patent/CA3098189C/en active Active
- 2019-04-25 US US16/395,099 patent/US10919878B2/en active Active
- 2019-04-25 AU AU2019317518A patent/AU2019317518B2/en active Active
- 2019-04-25 EP EP19847325.8A patent/EP3784650B1/en active Active
- 2019-04-25 JP JP2021509963A patent/JP7115671B2/ja active Active
- 2019-04-25 WO PCT/US2019/029192 patent/WO2020033019A2/en not_active Ceased
- 2019-04-25 CN CN201980035699.6A patent/CN112888673B/zh active Active